Leukaemia cure lies in cancer pill? Times of India City scientists Aditi Karmakar, Sudeshna Gangopadhyay and GS Bhattacharya have found out that rapamycin - a drug commonly used in the treatment of liver cancer - inhibits mTOR, the pathway for a multi-drug resistant gene that causes a relapse in AML ... |
